No such message found

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Precedence in Gene Therapy Pricing

I would agree that it is interesting, and I would agree that over the past 3 to 5 years (roughly) that the trend has been to lower highs but I would also say the trend has also been to higher lows over this same period. Last 3 years for sure. With the greater volume as of late and what I see as a converging chart I think a few positive news items could create a strong push up in SP.  Generally I find converging charts with increasing volume eventually leads to a hard pop one way or the other but I’m no expert  

All that being said I think this will remain a news driven story until such time that we see some serious, concrete progress not only in BoM but also with the other trials and hopefully with some of the other compounds on which we have heard talk from management but not seen anything of substance on.  JMO

 

Share
New Message
Please login to post a reply